Zevra Therapeutics ZVRA
NASDAQ ZVRA
$12.40 -0.14 (-1.12%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zevra Therapeutics (ZVRA) Inventory Average (2025 - 2026)

Zevra Therapeutics' (ZVRA) quarterly Inventory Average came in at $2.0 million in Q1 2026, down 10.58% YoY from $2.3 million in Q1 2025, and up 30.35% on a QoQ basis from $1.6 million in Q4 2025.

Analysis

Zevra Therapeutics (ZVRA) Inventory Average (2025 - 2026) Analysis & Trends

Zevra Therapeutics (ZVRA) has 2 years of Inventory Average data on file, last reported at $2.0 million in Q1 2026.

  • Quarterly Inventory Average fell 10.58% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 10.58% YoY) and the FY2025 annual result came in at $1.9 million, changed N/A from the prior year.
  • Inventory Average advanced to $2.0 million in Q1 2026, from $1.6 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $2.3 million in Q1 2025 to a low of $1.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.77 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 3.09 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 213.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 707.10 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 90.57 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 137.65 Mn
10 Zevra Therapeutics 734.60 Mn 513.03 Mn 38.18 Mn 2.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.38 Mn
Mar 31, 2026 2.03 Mn
Dec 31, 2025 1.55 Mn
Sep 30, 2025 1.24 Mn
Jun 30, 2025 1.83 Mn
Mar 31, 2025 2.26 Mn